Wang, X., Goldstein, D., Crowe, P. J., & Yang, J. (2016). Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: A review of the evidence. Onco Targets Ther.
Styl ChicagoWang, Xiaochun, David Goldstein, Philip J. Crowe, a Jia-Lin Yang. "Next-generation EGFR/HER Tyrosine Kinase Inhibitors for the Treatment of Patients With Non-small-cell Lung Cancer Harboring EGFR Mutations: A Review of the Evidence." Onco Targets Ther 2016.
Citace podle MLAWang, Xiaochun, David Goldstein, Philip J. Crowe, a Jia-Lin Yang. "Next-generation EGFR/HER Tyrosine Kinase Inhibitors for the Treatment of Patients With Non-small-cell Lung Cancer Harboring EGFR Mutations: A Review of the Evidence." Onco Targets Ther 2016.